The aim of this study was to evaluate SPARC expression in tumor and stromal cells, their prognostic value, and correlation with fibrosis, TAM infiltration, TIL density, PD‐L1 and PD‐1 levels in a large series of patients with non‐metastatic TNBC. The gene discussed is SPARC; the disease is neoplasm.